Calliditas Therapeutics

Recent Finacing

Debt

Recent Raise

$88.8M

Calliditas Therapeutics develops Nefecon and conducts clinical development, regulatory submission activities, and preparations for potential product launch and commercialization.

Founded 1991

Stockholms Lan, Sweden

51-100

Publicly Traded

calliditas.se

Highlights

Focus Areas

Biotechnology

Medical Device

Pharmaceutical

Recent Investors

Financials

$88.8M

Total Raised

1

Funding round

1

Investor

Team

Upgrade to view the team

See the team members at Calliditas Therapeutics.